Compare Recursion Pharmaceuticals Inc (RXRX) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Standard Lithium Ltd — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Standard Lithium Ltd trades at $2.27 (market cap $523.89M). The key difference: Recursion Pharmaceuticals Inc is far larger — about 2.9× Standard Lithium Ltd's market cap. Which is the better fit depends on your goals.
| RXRX | SLI | |
|---|---|---|
Market Cap | $1.53B | $523.89M |
Sector | Health | Basic Materials |
52-Week High | $6.79 | $5.65 |
52-Week Low | $2.84 | $2.15 |
Enterprise Value | $946.50M | $383.09M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
